STOCK TITAN
  1. Home
  2. Sec-filings
  3. DYN
  4. [Form 4] Dyne Therapeutics, Inc. Insider Trading Activity

[Form 4] Dyne Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock DYN logo
Dyne Therapeutics, Inc.

NASDAQ:DYN

DYN Rankings

#2106 Ranked by Market Cap
N/A Ranked by Dividends

DYN Latest News

Aug 27, 2025
Dyne Therapeutics to Present at Upcoming Investor Conferences
Aug 4, 2025
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)
Jul 28, 2025
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Jul 16, 2025
Satellos Appoints Dr. Wildon Farwell as Chief Medical Officer
Jul 2, 2025
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

DYN Latest SEC Filings

Sep 5, 2025
[144] Dyne Therapeutics, Inc. SEC Filing
Sep 4, 2025
[144] Dyne Therapeutics, Inc. SEC Filing
Aug 7, 2025
[SCHEDULE 13G/A] Dyne Therapeutics, Inc. SEC Filing
Aug 4, 2025
[8-K] Dyne Therapeutics, Inc. Reports Material Event
Jul 28, 2025
[8-K] Dyne Therapeutics, Inc. Reports Material Event

DYN Stock Data

1.88B
136.63M
0.49%
95.53%
11.46%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM